Patent Yard Sign in
Canadian application, no grantCanada

Visual marker for determining compliance with a medication regimen

CA 2434029 A1 · Owner: Pa2008 Corporation · Inventors: Griggs, Roger D.; Gonzales, Gilbert R.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method and combination including a visual marker for monitoring a patient to determine compliance with a medication regimen. An orally administrable medication composition is provided in combination with a visual marker. When the combination is orally ingested, the marker causes a coloration or discoloration of the oral and/or pharyngeal cavity of a subject. By visually observing the oral and/or pharyngeal cavity of the subject one can determine , whether medication has been ingested based upon the presence or absence of the coloration/discoloration.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 17, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 17, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 17, 2002
GrantedNo grant recorded
Term endedJanuary 17, 2022
Patent numberCA 2434029 A1
Classification (IPC)A61K49/00

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJan 17, 2002Term endedJan 17, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.